Following a tough period with headwinds from China and the transformation of Diagnostics, we expect the positive underlying trends to show through. Imaging, the backbone of the company, should profit from market share gains in volume and especially value terms from its unique photon-counting CT technology and from the market expansion by its Helium-free MRI scanner. For Diagnostics, we see only upside for investors from the two possible scenarios, a continuation of the turnaround or a potential ...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ARCELOR MITTAL, CELLNEX, SECTOR AUTOPISTAS, TALGO. EUROPA: AIRBUS, ING GROEP, PERNOD RICARD, SIEMENS, SOCIÉTÉ GÉNÉRALE. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’24 que se publicarán en España y Europa en los próximos días. El Ibex sigue imparable La sesión volvió a estar marcada por los comentari...
Our baseline scenario materialised last night: Donald Trump seems to be on course to win the US presidential election, and the choice of the electorate is unlikely to be challenged. He could end up with a majority in both houses of Congress. US equities will be the first to benefit from this development. In European equities, the biggest winners will be Energy, Media, Metals, Construction & Materials, Financial Services and Insurance. More at risk, however, are the Utilities, Spirits,...
Notre scénario central s’est concrétisé dans la nuit : Donald Trump remporte la présidentielle américaine, et le choix des électeurs ne devrait pas être contesté. Il pourrait disposer d’une majorité dans les deux assemblées. Les actions américaines en seront les premières bénéficiaires. Sur les actions européennes, les secteurs les plus gagnants seront l’Energie, les Médias, les Métaux, Construction & Materials, Financial Services, Insurance. Sont en revanche plus à risque Utilities, ...
>Q4 review – In line with expectations - Q4 revenues of € 6,329m (+4.5% y-o-y) were -1%/-1% below of ODDO BHF/consensus estimates. The comparable sales growth was 5.6% (vs 6.7%/5.6% expected). The equipment book-to-bill was at a level of 1.12x, following 1.07x at the Q3 results. Adjusted EBIT of € 1,120m (+10.6% y-o-y, margin 17.7%) was also -2%/0% vs expectation. Adjusted EPS of € 0.67 came in 3%/5% ahead of expectations. Reported EPS was € 0.55 (€ 0.56/€ 0.55 expect...
>Imaging continues to be impacted by China - Slower underlying dynamics in China have started initially on the back of the anti-corruption initiative, which has limited the access of sales reps to decision makers in hospitals. But the ongoing economic weakness in China has also currently some impact on the Imaging division. While we believe that the underlying demand for imaging equipment will outpace the overall economy, we expect some short-term headwinds coming fro...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.